- Login
- Register & Subscribe
- Language: EN FR DE
Research & University News
Roflumilast said to show improved lung function in Phase 3 COPD studies
Monday 31 August 2009
Roflumilast, a phosphodiesterase 4 (PDE4) inhibitor, has been reported to show an improvement in lung function in patients with chronic obstructive pulmonary disease in four Phase 3 trials published in The Lancet. The drug is produced by Nycomed.
Location
Switzerland
See map: Google Maps
Crucell receives funding for its malaria vaccine technology
Saturday 1 August 2009
Crucell NV of the Netherlands said the US government has agreed to fund further clinical studies of its adenovirus-based vaccine technology against the malaria parasite, Plasmodium falciparum.
Location
Netherlands
See map: Google Maps
UK National Cancer Research Institute launches new web portal
Monday 20 July 2009
A new web-based portal designed to help scientists and clinicians locate the latest cancer research has been launched by the UK National Cancer Research Institute (NCRI). The project is being funded by the UK government, charities and industry.
Location
United Kingdom
See map: Google Maps
Sanofi-aventis to decentralise research and development
Wednesday 1 July 2009
Sanofi-aventis has become the latest multinational pharmaceutical company to decentralise its research and development business in order to generate more ideas for new drugs from contact with scientists and entrepreneurs outside the company.
Location
France
Wellcome awards Novartis institute €5.15 million for vaccine project
Sunday 7 June 2009
The Wellcome Trust has awarded €5.15 million to a vaccine institute run by Novartis AG to investigate a new bivalent vaccine for Typhoid fever.
Location
United Kingdom
See map: Google Maps
Study looks at why pancreatic cancer drugs fail
Tuesday 26 May 2009
Scientists have described a mechanism that appears to explain why patients with pancreatic cancer can be resistant to the chemotherapy drug, gemcitabine. Their findings appear in the May 2009 issue of Science.
Location
United Kingdom
See map: Google Maps
Cancer Research UK to conduct first-in-man study of GSK drug
Wednesday 20 May 2009
Cancer Research UK has agreed to conduct a first-in-man study of a novel anti-cancer drug owned by GlaxoSmithKline, but not currently a priority of the UK multinational.
Location
United Kingdom
See map: Google Maps
AstraZeneca unit raises investment in Newcastle University programme
Sunday 17 May 2009
The AstraZeneca Plc subsidiary, KuDOS Pharmaceuticals Ltd, has increased its investment in a programme at Newcastle University that seeks to develop drugs inhibiting DNA-dependent protein kinase, thereby improving cancer treatments.
Location
United Kingdom
See map: Google Maps
Max Planck Innovation announces new venture capital fund
Thursday 14 May 2009
Max Planck Innovation GmbH, the technology transfer arm of the Max Planck Society, has announced the launch of a new €100 million fund to invest in pharmaceutical projects originating from the society’s research organisations.
Location
Germany
See map: Google Maps
Merck explains its external research programme
Saturday 25 April 2009
Merck & Co has become the latest big pharmaceutical company to announce plans to source a significant part of its biomedical research programmes from outside the company.
Location
United Kingdom
See map: Google Maps
Select a News Category
Recent Appointments
Tim Edwards elected chairman of BIA
Tuesday September 7 2010
Index Ventures appoints antibody expert as partner
Friday September 3 2010
Colin Stewart appointed CEO at Amarin
Friday August 20 2010
Karl Keegan nominated as CFO of Pharming
Friday August 20 2010
Axel Müller becomes CEO at SkyePharma
Thursday August 19 2010